Indical Inc.

San Francisco, CA

UEI
NSAPUP5KD7F6
CAGE
8HPN8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
100 Montgomery St #1780, San Francisco, CA 94104, USA
Website
indical.com
Founded
2018
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $103,360
FY2025 $66,042
FY2024 $42,540

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Agriculture $103,360

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Indical Inc., a foreign-owned small business based in San Francisco, California, supplies tuberculosis diagnostic test kits to the U.S. Department of Agriculture's Veterinary Services division as a 100% prime contractor on full-and-open (non-set-aside) delivery orders and a single-award indefinite delivery contract. The company is a for-profit small business joint venture with self-certified small disadvantaged business status.

Indical's federal footprint is concentrated entirely within a single customer agency and a single product line. The Department of Agriculture's Animal and Plant Health Inspection Service Veterinary Services accounts for seven of eight awards and $613 thousand of the $626 thousand combined potential value; the Animal and Plant Health Inspection Service proper accounts for one purchase order worth $13 thousand. All work centers on QuantiFERON Gold test kits, specialized in vitro diagnostic tools used for tuberculosis detection in cattle and other animal populations supporting disease surveillance and monitoring in livestock health programs. Representative recent awards include a $145,900 delivery order issued April 1, 2026, for 200 QuantiFERON Gold test kits with an ultimate completion date of April 30, 2026 (place of performance Ames, Iowa); a $30,792 delivery order from July 2025 for the same kits; and a $25,248 delivery order from February 2025 with an ultimate completion date of March 10, 2025. Indical also holds the parent single-award indefinite delivery contract valued at $350 thousand with Veterinary Services, running through December 31, 2026, which anchors five task orders carrying $212 thousand in combined potential value.

Activity has been episodic — one award in 2021, one in 2022, three in 2024, two in 2025, and one in 2026 — with no apparent growth trajectory. The vendor's category coding aligns with research and development in biotechnology across all eight awards, with six awards classified under in vitro diagnostic substances and test kits (PSC codes). Place of performance varies; one December 2024 order notes Mexico as the location, while more recent orders specify Ames, Iowa. No subcontract activity appears in the source.

Quick answers

Is Indical Inc. registered in SAM.gov?

Yes. Indical Inc.'s SAM.gov registration is active through February 11, 2027.

How much has Indical Inc. received in federal contracts?

Federal contracts obligated $66,042 to Indical Inc. in fiscal year 2025 and $211,942 in fiscal years 2023 through 2027.

What is Indical Inc.'s most recent federal award?

Indical Inc.'s most recent federal contract award is Quantiferon gold test kits (200 QFT kits) (12639526F0363), from Marketing and Regulatory Programs Business Services (APHIS), on April 1, 2026.

On GovTribe

See Indical Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors